{"id":2792,"date":"2026-07-22T20:16:37","date_gmt":"2026-07-22T23:16:37","guid":{"rendered":"https:\/\/inovamed.pro\/?p=2792"},"modified":"2026-07-22T20:16:50","modified_gmt":"2026-07-22T23:16:50","slug":"a-ia-que-preve-complicacao-cardiaca-infantil-e-a-armadilha-que-ninguem-mostra","status":"publish","type":"post","link":"https:\/\/inovamed.pro\/?p=2792","title":{"rendered":"A IA Que Prev\u00ea Complica\u00e7\u00e3o Card\u00edaca Infantil \u2014 e a Armadilha Que Ningu\u00e9m Mostra"},"content":{"rendered":"<div id=\"cfm-root\" class=\"ino-fullbleed\">\n<style>\n@import url('https:\/\/fonts.googleapis.com\/css2?family=Outfit:wght@300;400;500;600;700;800&display=swap');\n@scope (#cfm-root) {\n:scope {\n--primary: #0066CC;\n--secondary: #00A859;\n--accent: #FF6B35;\n--dark: #1E293B;\n--light: #F8FAFC;\n--gradient: linear-gradient(135deg, var(--primary), var(--secondary));\n--gradient-accent: linear-gradient(135deg, var(--accent), #FF8C61);\n}\n* { margin: 0; padding: 0; box-sizing: border-box; }\n:scope { font-family: 'Outfit', sans-serif; color: var(--dark); line-height: 1.8; background: var(--light); overflow-x: hidden; text-rendering: optimizeLegibility; }\n.nav-buttons { position: fixed; bottom: 30px; right: 30px; z-index: 999; display: flex; flex-direction: column; gap: 12px; }\n.nav-btn { width: 56px; height: 56px; border-radius: 50%; background: var(--gradient); color: white; border: none; cursor: pointer; font-size: 1.3rem; box-shadow: 0 6px 24px rgba(0,102,204,0.3); transition: all 0.3s; display: flex; align-items: center; justify-content: center; text-decoration: none; }\n.nav-btn:hover { transform: translateY(-4px); box-shadow: 0 8px 32px rgba(0,102,204,0.4); }\n.nav-btn.secondary { background: linear-gradient(135deg, #64748B, #475569); }\n.language-toggle { position: fixed; top: 20px; right: 20px; z-index: 1000; background: white; padding: 12px 24px; border-radius: 30px; box-shadow: 0 4px 20px rgba(0,0,0,0.1); display: flex; gap: 15px; align-items: center; }\n.lang-btn { background: none; border: 2px solid var(--primary); color: var(--primary); padding: 8px 20px; border-radius: 20px; cursor: pointer; font-weight: 600; transition: all 0.3s; font-family: 'Outfit', sans-serif; }\n.lang-btn.active { background: var(--gradient); color: white; border-color: transparent; }\n.lang-btn:hover { transform: translateY(-2px); box-shadow: 0 4px 12px rgba(0,102,204,0.3); }\n.hero { background: var(--gradient); color: white; padding: 120px 20px 80px; text-align: center; position: relative; overflow: hidden; }\n.hero::before { content: ''; position: absolute; top: -50%; right: -10%; width: 600px; height: 600px; background: rgba(255,255,255,0.08); border-radius: 50%; animation: cfm-float 20s infinite ease-in-out; }\n.hero h1 { font-size: clamp(2rem, 5vw, 3rem); font-weight: 800; margin-bottom: 25px; line-height: 1.2; position: relative; z-index: 1; }\n.hero .subtitle { font-size: clamp(1.05rem, 3vw, 1.3rem); margin-bottom: 20px; opacity: 0.95; font-weight: 400; line-height: 1.6; max-width: 900px; margin-left: auto; margin-right: auto; }\n.hero .meta-info { font-size: clamp(0.9rem, 2.5vw, 1rem); opacity: 0.9; margin-top: 25px; font-weight: 500; }\n.hero .date { font-size: clamp(0.85rem, 2vw, 0.95rem); opacity: 0.85; margin-top: 12px; font-style: italic; }\n.deadline-badge { display: inline-block; background: rgba(255,255,255,0.18); border: 2px solid rgba(255,255,255,0.55); color: white; padding: 12px 30px; border-radius: 30px; font-size: 1.05rem; font-weight: 700; margin-top: 25px; position: relative; z-index: 1; letter-spacing: 0.02em; }\n.container { width: 100%; max-width: 1200px; margin: 0 auto; padding: clamp(40px, 8vw, 80px) clamp(15px, 4vw, 20px); }\n.section { margin-bottom: 80px; }\n.section-title { font-size: clamp(1.8rem, 4.5vw, 2.3rem); font-weight: 700; margin-bottom: 30px; color: var(--dark); position: relative; padding-bottom: 15px; }\n.section-title::after { content: ''; position: absolute; bottom: 0; left: 0; width: 80px; height: 4px; background: var(--gradient); border-radius: 2px; }\n.toc { background: linear-gradient(135deg, #ffffff, #f8fafc); padding: clamp(30px, 5vw, 50px) clamp(25px, 4vw, 45px); border-radius: 24px; margin-bottom: 60px; box-shadow: 0 15px 60px rgba(0,0,0,0.12); border: 1px solid rgba(0,102,204,0.1); position: relative; overflow: hidden; }\n.toc::before { content: ''; position: absolute; top: 0; left: 0; width: 6px; height: 100%; background: var(--gradient); }\n.toc h2 { font-size: clamp(1.6rem, 3.5vw, 2rem); color: var(--dark); margin-bottom: 15px; font-weight: 700; display: flex; align-items: center; gap: 15px; }\n.toc h2::before { content: '\ud83e\udded'; font-size: 1.8rem; }\n.toc-subtitle { font-size: 1.05rem; color: #64748B; margin-bottom: 35px; font-weight: 400; }\n.toc ul { list-style: none; padding-left: 0; display: grid; grid-template-columns: 1fr; gap: 12px; }\n.toc ul li { margin-bottom: 0; }\n.toc ul li a { display: flex; align-items: center; gap: 15px; text-decoration: none; color: var(--dark); font-weight: 600; font-size: clamp(0.95rem, 2.5vw, 1.1rem); padding: 18px 22px; background: white; border-radius: 12px; transition: all 0.3s; border: 2px solid transparent; box-shadow: 0 2px 8px rgba(0,0,0,0.04); }\n.toc ul li a::before { content: ''; width: 8px; height: 8px; background: var(--gradient); border-radius: 50%; flex-shrink: 0; }\n.toc ul li a:hover { transform: translateX(8px); border-color: var(--primary); box-shadow: 0 8px 24px rgba(0,102,204,0.15); background: linear-gradient(135deg, #ffffff, #f0f9ff); }\n.intro-box { background: white; padding: clamp(25px, 4vw, 40px); border-radius: 20px; box-shadow: 0 10px 40px rgba(0,0,0,0.08); margin-bottom: 60px; border-left: 6px solid var(--primary); }\n.intro-box p { font-size: clamp(1rem, 2.8vw, 1.15rem); line-height: 1.9; margin-bottom: 20px; text-align: justify; }\n.intro-box p:last-child { margin-bottom: 0; }\n.intro-box strong { color: var(--primary); font-weight: 700; }\n.detailed-section { background: white; padding: clamp(30px, 5vw, 50px); border-radius: 20px; box-shadow: 0 10px 40px rgba(0,0,0,0.08); margin: 40px 0; }\n.detailed-section h3 { font-size: clamp(1.5rem, 3.8vw, 1.8rem); color: var(--primary); margin-bottom: 20px; font-weight: 700; }\n.detailed-section h4 { font-size: clamp(1.2rem, 3vw, 1.4rem); color: var(--dark); margin: 28px 0 16px; font-weight: 600; }\n.detailed-section p { font-size: clamp(1rem, 2.5vw, 1.1rem); line-height: 1.9; margin-bottom: 18px; text-align: justify; }\n.detailed-section ul, .detailed-section ol { font-size: clamp(1rem, 2.5vw, 1.1rem); line-height: 1.9; margin: 16px 0 16px 30px; padding-left: 20px; }\n.detailed-section li { margin-bottom: 8px; }\n.highlight-box { background: linear-gradient(135deg, #E6F3FF, #D6EBFF); padding: clamp(25px, 4vw, 40px); border-radius: 15px; margin: 40px 0; border-left: 6px solid var(--primary); }\n.highlight-box h4 { font-size: clamp(1.2rem, 3vw, 1.4rem); color: var(--primary); margin-bottom: 18px; font-weight: 700; }\n.highlight-box p { font-size: clamp(1rem, 2.8vw, 1.1rem); line-height: 1.8; margin-bottom: 12px; text-align: justify; }\n.highlight-box strong { color: var(--primary); font-weight: 700; }\n.highlight-box ul { font-size: clamp(1rem, 2.5vw, 1.05rem); line-height: 1.9; margin: 14px 0 14px 28px; padding-left: 18px; }\n.highlight-box li { margin-bottom: 8px; }\n.warning-box { background: linear-gradient(135deg, #FFF9E6, #FFF3D6); padding: clamp(25px, 4vw, 40px); border-radius: 15px; margin: 40px 0; border-left: 6px solid var(--accent); }\n.warning-box h4 { font-size: clamp(1.2rem, 3vw, 1.4rem); color: var(--accent); margin-bottom: 18px; font-weight: 700; }\n.warning-box p { font-size: clamp(1rem, 2.8vw, 1.1rem); line-height: 1.9; margin-bottom: 14px; text-align: justify; }\n.warning-box strong { color: #C05800; font-weight: 700; }\n.warning-box ul { font-size: clamp(1rem, 2.5vw, 1.05rem); line-height: 1.9; margin: 14px 0 14px 28px; padding-left: 18px; }\n.warning-box li { margin-bottom: 8px; }\n.science-box { background: linear-gradient(135deg, #E6FFF6, #CCFFE6); border: 2px solid var(--secondary); border-radius: 15px; padding: clamp(25px, 4vw, 35px); margin: 30px 0; }\n.science-box h4 { color: var(--secondary); font-weight: 700; font-size: 1.3em; margin-bottom: 15px; display: flex; align-items: center; }\n.science-box h4::before { content: \"\ud83d\udca1\"; margin-right: 10px; }\n.science-box p { font-size: 1.05rem; text-align: justify; margin-bottom: 14px; line-height: 1.85; }\n.science-box p:last-child { margin-bottom: 0; }\n.alert-box { background: linear-gradient(135deg, #FFF0F0, #FFE0E0); border: 2px solid #FC8181; border-radius: 15px; padding: clamp(25px, 4vw, 35px); margin: 30px 0; }\n.alert-box h4 { color: #C53030; font-weight: 700; font-size: 1.3em; margin-bottom: 15px; }\n.alert-box p { font-size: 1.05rem; text-align: justify; margin-bottom: 14px; line-height: 1.85; }\n.alert-box strong { color: #C53030; }\n.flow-box { background: radial-gradient(circle at top left, #1e293b, #020617); color: #e5e7eb; border-radius: 22px; padding: 28px 26px; margin: 40px 0; box-shadow: 0 18px 50px rgba(15,23,42,0.65); border: 1px solid rgba(148,163,184,0.4); position: relative; overflow: hidden; }\n.flow-box::before { content: \"\"; position: absolute; top: -80px; right: -80px; width: 220px; height: 220px; background: radial-gradient(circle, rgba(56,189,248,0.35), transparent 70%); opacity: 0.5; }\n.flow-box h4 { font-size: clamp(1.35rem, 3vw, 1.6rem); margin-bottom: 8px; font-weight: 700; display: flex; align-items: center; gap: 10px; color: #f9fafb; text-shadow: 0 2px 8px rgba(0,0,0,0.7); }\n.flow-box h4::before { content: \"\ud83d\udcc5\"; font-size: 1.4rem; }\n.flow-box p.flow-intro { font-size: 0.98rem; opacity: 0.9; max-width: 650px; margin-bottom: 0; }\n.flow-steps { margin-top: 22px; display: flex; flex-wrap: wrap; gap: 14px; align-items: stretch; position: relative; z-index: 1; }\n.flow-step { flex: 1 1 150px; background: rgba(15,23,42,0.92); border-radius: 16px; padding: 16px; border: 1px solid rgba(148,163,184,0.4); backdrop-filter: blur(4px); }\n.flow-step.current { border-color: #60A5FA; border-width: 2px; background: rgba(20,50,100,0.95); }\n.flow-step .step-label { font-size: 0.72rem; text-transform: uppercase; letter-spacing: 0.12em; color: #a5b4fc; margin-bottom: 5px; }\n.flow-step.current .step-label { color: #93C5FD; }\n.flow-step .step-title { font-size: 0.95rem; font-weight: 700; margin-bottom: 5px; color: #e5e7eb; }\n.flow-step .step-desc { font-size: 0.86rem; opacity: 0.88; line-height: 1.5; }\n.flow-arrow { font-size: 1.6rem; align-self: center; padding: 0 4px; opacity: 0.8; }\n.table-wrapper { overflow-x: auto; -webkit-overflow-scrolling: touch; margin: 40px 0; border-radius: 15px; box-shadow: 0 8px 30px rgba(0,0,0,0.06); }\n.data-table { width: 100%; min-width: 620px; border-collapse: collapse; background: white; overflow: hidden; }\n.data-table th, .data-table td { padding: 18px 20px; text-align: left; border-bottom: 1px solid #E2E8F0; }\n.data-table th { background: var(--gradient); color: white; font-weight: 700; font-size: 1rem; }\n.data-table td { font-size: 1rem; line-height: 1.6; vertical-align: top; }\n.data-table tr:last-child td { border-bottom: none; }\n.data-table tr:hover td { background: #F8FAFC; }\n.status-badge { display: inline-block; padding: 5px 14px; border-radius: 20px; font-size: 0.88em; font-weight: 700; white-space: nowrap; }\n.s-baixo { background: #C6F6D5; color: #22543D; }\n.s-medio { background: #BEE3F8; color: #2A4365; }\n.s-alto { background: #FEEBC8; color: #7C2D12; }\n.s-inaceitavel { background: #E9D8FD; color: #44337A; }\n.checklist-section { padding: 10px 0; }\n.check-item { display: flex; align-items: flex-start; gap: 14px; padding: 12px 0; border-bottom: 1px solid rgba(0,102,204,0.1); }\n.check-item:last-child { border-bottom: none; }\n.check-icon { font-size: 1.25rem; flex-shrink: 0; margin-top: 1px; }\n.check-text { flex: 1; line-height: 1.65; font-size: 1rem; }\n.check-text strong { color: var(--primary); font-weight: 700; }\n.check-subhead { font-size: 1.05rem; font-weight: 700; color: var(--dark); margin: 20px 0 10px; padding-bottom: 6px; border-bottom: 2px solid rgba(0,102,204,0.2); }\n.cta-section { background: var(--gradient); color: white; padding: clamp(60px, 10vw, 80px) clamp(30px, 6vw, 40px); border-radius: 25px; text-align: center; margin: 80px 0; position: relative; overflow: hidden; }\n.cta-section::before { content: ''; position: absolute; top: -50%; left: -50%; width: 600px; height: 600px; background: rgba(255,255,255,0.07); border-radius: 50%; animation: cfm-float 15s infinite ease-in-out; }\n.cta-section h2 { font-size: clamp(1.8rem, 4.5vw, 2.3rem); margin-bottom: 25px; position: relative; z-index: 1; }\n.cta-section p { font-size: clamp(1.05rem, 3vw, 1.2rem); margin-bottom: 20px; opacity: 0.95; position: relative; z-index: 1; line-height: 1.8; max-width: 800px; margin-left: auto; margin-right: auto; }\n.cta-button { display: inline-block; background: white; color: var(--primary); padding: 15px 40px; border-radius: 30px; text-decoration: none; font-weight: 700; font-size: 1.1em; transition: all 0.3s ease; box-shadow: 0 4px 15px rgba(0,0,0,0.2); margin-top: 20px; position: relative; z-index: 1; }\n.cta-button:hover { transform: translateY(-2px); box-shadow: 0 6px 20px rgba(0,0,0,0.3); }\n.footer { background: var(--dark); color: white; padding: 50px 20px; text-align: center; }\n.footer p { font-size: 1rem; opacity: 0.8; margin-bottom: 10px; line-height: 1.7; }\n.reference-box { background: #F8FAFC; padding: clamp(22px, 4vw, 30px); border-radius: 15px; margin: 40px 0; border-left: 4px solid var(--secondary); }\n.reference-box h4 { font-size: 1.2rem; color: var(--secondary); margin-bottom: 15px; font-weight: 700; }\n.reference-box ol { font-size: 0.93rem; line-height: 1.85; color: #64748B; margin-left: 10px; padding-left: 20px; }\n.reference-box li { margin-bottom: 10px; }\n.divider { height: 1px; background: linear-gradient(90deg, transparent, rgba(0,102,204,0.25), transparent); margin: 50px 0; }\n.hidden { display: none; }\n.article-tag { display: inline-block; background: rgba(255,255,255,0.18); color: white; padding: 4px 16px; border-radius: 20px; font-size: 0.85rem; font-weight: 600; margin-bottom: 18px; border: 1px solid rgba(255,255,255,0.4); position: relative; z-index: 1; }\n@media (max-width: 768px) {\n.language-toggle { top: 10px; right: 10px; padding: 8px 16px; gap: 8px; }\n.lang-btn { padding: 6px 14px; font-size: 0.9rem; }\n.nav-buttons { bottom: 20px; right: 20px; }\n.nav-btn { width: 50px; height: 50px; font-size: 1.1rem; }\n.flow-steps { flex-direction: column; }\n.flow-arrow { transform: rotate(90deg); text-align: center; }\n}\n@media (max-width: 480px) {\n.container { padding: 30px 15px; }\n.intro-box, .detailed-section, .highlight-box, .warning-box, .science-box, .alert-box { padding: 22px; }\n}\n}\n@keyframes cfm-float { 0%, 100% { transform: translateY(0) rotate(0deg); } 50% { transform: translateY(-30px) rotate(180deg); } }\n@keyframes cfm-fadeIn { from { opacity: 0; transform: translateY(10px); } to { opacity: 1; transform: translateY(0); } }\n<\/style>\n<div class=\"nav-buttons\">\n<a href=\"#top-pt\" id=\"nav-btn-top\" class=\"nav-btn\" title=\"Topo\">\u2191<\/a>\n<a href=\"#indice-pt\" id=\"nav-btn-toc\" class=\"nav-btn secondary\" title=\"\u00cdndice\">\ud83e\udded<\/a>\n<\/div>\n<div class=\"language-toggle\">\n<button class=\"lang-btn active\" onclick=\"switchLanguage('pt')\" id=\"btn-pt\">\ud83c\udde7\ud83c\uddf7 PT<\/button>\n<button class=\"lang-btn\" onclick=\"switchLanguage('en')\" id=\"btn-en\">\ud83c\uddfa\ud83c\uddf8 EN<\/button>\n<\/div>\n<!-- ===================== CONTE\u00daDO PT ===================== -->\n<div id=\"content-pt\">\n<section class=\"hero\" id=\"top-pt\">\n<span class=\"article-tag\">Cardiologia Pedi\u00e1trica \u00b7 Machine Learning \u00b7 UTI<\/span>\n<h1>A IA Que Prev\u00ea Complica\u00e7\u00e3o Card\u00edaca Infantil \u2014 e a Armadilha Que Ningu\u00e9m Mostra<\/h1>\n<p class=\"subtitle\">A safra recente trouxe modelos de machine learning que antecipam baixo d\u00e9bito, les\u00e3o renal e reintuba\u00e7\u00e3o no p\u00f3s-operat\u00f3rio card\u00edaco pedi\u00e1trico com AUC perto de 0,90 \u2014 ou seja, entre duas crian\u00e7as, acertam quase sempre qual delas tem o maior risco de complicar, batendo muitos escores cl\u00e1ssicos. Mas h\u00e1 um n\u00famero que quase nenhum post exibe: longe do hospital onde nasceram, a sensibilidade \u2014 a fra\u00e7\u00e3o das crian\u00e7as em risco que o modelo de fato detecta \u2014 despenca. Entender essa queda \u00e9 o que separa importar um modelo de paper de construir uma ferramenta que sobrevive \u00e0 sua UTI.<\/p>\n<p class=\"meta-info\">Dr. Mbula Luzingu Barros | M\u00e9dico Pediatra Intensivista \u00b7 25 anos de UTI Pedi\u00e1trica | Consultor em IA na Sa\u00fade | Fundador da INOVAMED | Criador da Metodologia AIMED<\/p>\n<p class=\"date\">\ud83d\udcc5 Publicado em 22 de julho de 2026<\/p>\n<div class=\"deadline-badge\">\u23f1 Vig\u00eancia plena da CFM 2.454 em: <span class=\"countdown-days\">35<\/span> dias \u2014 26 de agosto de 2026<\/div>\n<\/section>\n<div class=\"container\">\n<nav class=\"toc\" id=\"indice-pt\">\n<h2>Navegue pelo Artigo<\/h2>\n<p class=\"toc-subtitle\">Do desfecho de beira-leito \u00e0 recalibra\u00e7\u00e3o local \u2014 o trabalho cl\u00ednico que come\u00e7a depois do download do modelo<\/p>\n<ul>\n<li><a href=\"#ctx-pt\">1. Por Que Isso Importa Pra Quem Trabalha na Ponta<\/a><\/li>\n<li><a href=\"#safra-pt\">2. O Que a Safra Recente Entregou<\/a><\/li>\n<li><a href=\"#num-pt\">3. Os N\u00fameros, Sem Filtro<\/a><\/li>\n<li><a href=\"#armadilha-pt\">4. A Armadilha da Valida\u00e7\u00e3o Externa<\/a><\/li>\n<li><a href=\"#recalib-pt\">5. Recalibra\u00e7\u00e3o Local Como Ato Cl\u00ednico<\/a><\/li>\n<li><a href=\"#cfm-pt\">6. A Camada Regulat\u00f3ria \u2014 CFM 2.454<\/a><\/li>\n<li><a href=\"#tl-pt\">7. A Linha do Tempo<\/a><\/li>\n<li><a href=\"#fazer-pt\">8. O Que Fazer na Segunda-Feira<\/a><\/li>\n<li><a href=\"#final-pt\">9. Considera\u00e7\u00f5es Finais<\/a><\/li>\n<li><a href=\"#ref-pt\">10. Refer\u00eancias<\/a><\/li>\n<\/ul>\n<\/nav>\n<section class=\"section\" id=\"ctx-pt\">\n<h2 class=\"section-title\">Por Que Isso Importa Pra Quem Trabalha na Ponta<\/h2>\n<div class=\"intro-box\">\n<p>O p\u00f3s-operat\u00f3rio de uma cirurgia card\u00edaca cong\u00eanita \u00e9 uma das janelas mais tensas da UTI pedi\u00e1trica. Tr\u00eas sombras rondam a primeira semana: a <strong>s\u00edndrome de baixo d\u00e9bito<\/strong> (LCOS), a <strong>les\u00e3o renal aguda<\/strong> (AKI) associada \u00e0 circula\u00e7\u00e3o extracorp\u00f3rea e a <strong>reintuba\u00e7\u00e3o<\/strong> ap\u00f3s um desmame que parecia seguro. S\u00e3o desfechos que a gente aprende a farejar com anos de plant\u00e3o \u2014 mudan\u00e7a sutil na perfus\u00e3o, no lactato, no ritmo de diurese.<\/p>\n<p>Nos \u00faltimos anos, uma safra consistente de modelos de machine learning passou a antecipar exatamente essas tr\u00eas complica\u00e7\u00f5es, com desempenho que, no papel, supera boa parte dos escores tradicionais que ainda usamos \u00e0 beira do leito. A promessa \u00e9 sedutora: um sistema que sinaliza o risco horas antes do olho treinado. Mas h\u00e1 um detalhe t\u00e9cnico \u2014 <strong>invis\u00edvel para quem l\u00ea s\u00f3 o abstract<\/strong> \u2014 que decide se esse modelo vai ajudar ou atrapalhar na sua unidade. \u00c9 sobre ele que este artigo se debru\u00e7a.<\/p>\n<\/div>\n<\/section>\n<div class=\"divider\"><\/div>\n<section class=\"section\" id=\"safra-pt\">\n<h2 class=\"section-title\">O Que a Safra Recente Entregou<\/h2>\n<div class=\"detailed-section\">\n<p>Os modelos recentes atacam os tr\u00eas desfechos de frente. Para o <strong>baixo d\u00e9bito em neonatos<\/strong>, um estudo recente treinou modelos de gradient boosting (LightGBM) numa coorte de 181 neonatos, dos quais 14,9% desenvolveram LCOS, atingindo AUROC de 0,91 a 0,98 conforme o horizonte de previs\u00e3o (de 2 a 12 horas \u00e0 frente). Para a mesma s\u00edndrome em popula\u00e7\u00e3o pedi\u00e1trica mais ampla, outro modelo LightGBM alcan\u00e7ou AUC de 0,893. Os preditores que os algoritmos elegeram n\u00e3o surpreendem nenhum intensivista: escore vasoativo-inotr\u00f3pico (VIS) elevado, d\u00e9bito urin\u00e1rio baixo e lactato s\u00e9rico alto no modelo neonatal; e tempo de ventila\u00e7\u00e3o mec\u00e2nica como principal contribuinte no modelo pedi\u00e1trico de maior porte.<\/p>\n<h4>Les\u00e3o renal e reintuba\u00e7\u00e3o<\/h4>\n<p>Para a <strong>AKI p\u00f3s-circula\u00e7\u00e3o extracorp\u00f3rea<\/strong>, uma meta-an\u00e1lise de 2026 agregou sete estudos, somando quase 12 mil crian\u00e7as, e encontrou uma AUC agrupada (SROC) de 0,91. Para a <strong>reintuba\u00e7\u00e3o<\/strong>, uma rede neural multicamada modelou um dos gargalos mais frustrantes do desmame p\u00f3s-cir\u00fargico. O recado quantitativo \u00e9 coerente: em discrimina\u00e7\u00e3o, esses modelos batem escores como o RACHS-1 isolado e rivalizam com a leitura cl\u00ednica experiente.<\/p>\n<\/div>\n<div class=\"warning-box\">\n<h4>\u26a0 Discrimina\u00e7\u00e3o boa n\u00e3o \u00e9 a mesma coisa que confian\u00e7a cl\u00ednica<\/h4>\n<p>Uma AUC de 0,91 diz que o modelo <strong>ordena bem o risco<\/strong> \u2014 coloca em ordem quem tem mais e menos chance de complicar. Ela n\u00e3o diz que a <strong>probabilidade absoluta<\/strong> que ele cospe (\u201c68% de chance de AKI\u201d) corresponde \u00e0 realidade da sua popula\u00e7\u00e3o. E, principalmente, o n\u00famero reluzente quase sempre vem da valida\u00e7\u00e3o interna \u2014 o modelo testado na mesma casa onde nasceu. O comportamento fora de casa \u00e9 outra hist\u00f3ria.<\/p>\n<\/div>\n<div class=\"highlight-box\">\n<h4>Um exemplo concreto: o que \u201cprever\u201d significa aqui<\/h4>\n<p>Imagine um rec\u00e9m-nascido que acabou de sair de uma cirurgia de Norwood e chega \u00e0 UTI \u00e0s duas da manh\u00e3. No monitor, ainda est\u00e1 tudo est\u00e1vel. Em segundo plano, o modelo l\u00ea as mesmas vari\u00e1veis que voc\u00ea olharia \u2014 lactato, ritmo de diurese, dose de inotr\u00f3pico, tempo de circula\u00e7\u00e3o extracorp\u00f3rea \u2014 e devolve um sinal: <strong>\u201crisco alto de les\u00e3o renal nas pr\u00f3ximas 24 horas\u201d<\/strong>. Na pr\u00e1tica, isso n\u00e3o muda o diagn\u00f3stico; muda a <em>vigil\u00e2ncia<\/em>. Voc\u00ea antecipa a coleta de creatinina, segura uma droga nefrot\u00f3xica, pede \u00e0 enfermagem para cronometrar a diurese de hora em hora. O modelo n\u00e3o decide nada \u2014 ele aponta onde o seu olho deve pousar primeiro.<\/p>\n<\/div>\n<\/section>\n<div class=\"divider\"><\/div>\n<section class=\"section\" id=\"num-pt\">\n<h2 class=\"section-title\">Os N\u00fameros, Sem Filtro<\/h2>\n<p style=\"font-size:clamp(1rem,2.5vw,1.1rem);line-height:1.9;text-align:justify;margin-bottom:8px;\">Antes de olhar a tabela, vale ter tr\u00eas siglas na ponta da l\u00edngua. Elas parecem \u00e1ridas, mas cada uma responde a uma pergunta que voc\u00ea j\u00e1 faz de cabe\u00e7a no plant\u00e3o \u2014 s\u00f3 que sem nome t\u00e9cnico.<\/p>\n<div class=\"science-box\">\n<h4>O tradutor de siglas (guarde estas tr\u00eas)<\/h4>\n<p><strong>AUC (ou AUROC) \u2014 \u201co modelo sabe ordenar o risco?\u201d<\/strong> Imagine sortear duas crian\u00e7as, uma que vai complicar e outra que n\u00e3o. A AUC \u00e9 a probabilidade de o modelo dar a nota de risco mais alta justamente para a que complica. <strong>0,50 \u00e9 cara ou coroa<\/strong> (in\u00fatil), <strong>1,00 \u00e9 perfei\u00e7\u00e3o<\/strong>, e <strong>0,90 quer dizer que ele ganha essa aposta 9 em cada 10 vezes<\/strong>. Repare: \u00e9 uma nota de <em>ordena\u00e7\u00e3o<\/em> entre pacientes \u2014 n\u00e3o uma certeza sobre um paciente isolado.<\/p>\n<p><strong>Sensibilidade \u2014 \u201cde quem ia complicar, quantos ele pega?\u201d<\/strong> Sensibilidade 0,84 significa que, de 100 crian\u00e7as que realmente v\u00e3o complicar, o modelo acende o alerta em 84; as outras 16 passam despercebidas (os falsos negativos). Na UTI, \u00e9 a m\u00e9trica que mais d\u00f3i errar \u2014 \u00e9 crian\u00e7a que deteriora sem vigil\u00e2ncia extra.<\/p>\n<p><strong>Especificidade \u2014 \u201cde quem estava bem, quantos ele deixa em paz?\u201d<\/strong> Especificidade 0,95 significa que, de 100 crian\u00e7as que <em>n\u00e3o<\/em> v\u00e3o complicar, s\u00f3 5 recebem alarme \u00e0 toa (os falsos positivos). Especificidade baixa \u00e9 a m\u00e3e do <em>alarm fatigue<\/em>: o monitor que grita tanto que ningu\u00e9m mais escuta.<\/p>\n<p><strong>E a AUPRC?<\/strong> \u00c9 a prima da AUC, mas honesta quando o evento \u00e9 <em>raro<\/em>. Quando s\u00f3 1 em cada 20 crian\u00e7as complica, a AUC pode parecer enganosamente linda; a AUPRC n\u00e3o deixa a peteca cair. Por isso o estudo do LCOS neonatal reporta as duas (AUROC 0,91\u20130,98 e AUPRC 0,60\u20130,80) \u2014 a segunda \u00e9 o teste de realidade da primeira.<\/p>\n<\/div>\n<div class=\"table-wrapper\">\n<table class=\"data-table\">\n<thead>\n<tr>\n<th>Refer\u00eancia<\/th>\n<th>Desfecho \/ Vari\u00e1vel<\/th>\n<th>Valor<\/th>\n<th>Fonte<\/th>\n<th>Leitura<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr><td>2025<\/td><td>LCOS neonatal \u2014 AUROC<\/td><td>AUROC 0,91\u20130,98 (AUPRC 0,60\u20130,80; n=181; 14,9% LCOS)<\/td><td>Baloglu et al. \u00b7 Crit Care Explor<\/td><td><span class=\"status-badge s-medio\">\u2191 bom<\/span><\/td><\/tr>\n<tr><td>2024<\/td><td>LCOS pedi\u00e1trico \u2014 AUC (LightGBM)<\/td><td>0,893 (IC95% 0,884\u20130,895)<\/td><td>Coorte retrospectiva \u00b7 Int J Surg<\/td><td><span class=\"status-badge s-medio\">\u2191 bom<\/span><\/td><\/tr>\n<tr><td>2026<\/td><td>AKI p\u00f3s-CEC \u2014 AUC agrupada (SROC)<\/td><td>0,91 (IC95% 0,88\u20130,93; 7 estudos; ~12 mil crian\u00e7as)<\/td><td>Meta-an\u00e1lise \u00b7 Front Cardiovasc Med<\/td><td><span class=\"status-badge s-medio\">\u2191 bom<\/span><\/td><\/tr>\n<tr><td>2026<\/td><td>AKI \u2014 valida\u00e7\u00e3o <em>interna<\/em> (Sens \/ Espec)<\/td><td>0,84 \/ 0,95<\/td><td>Meta-an\u00e1lise \u00b7 Front Cardiovasc Med<\/td><td><span class=\"status-badge s-baixo\">\u2191 \u00f3timo (no ber\u00e7o)<\/span><\/td><\/tr>\n<tr><td>2026<\/td><td>AKI \u2014 valida\u00e7\u00e3o <em>externa<\/em> (Sens \/ Espec)<\/td><td>0,70 \/ 0,80<\/td><td>Meta-an\u00e1lise \u00b7 Front Cardiovasc Med<\/td><td><span class=\"status-badge s-alto\">\u2193 cai fora de casa<\/span><\/td><\/tr>\n<tr><td>2026<\/td><td>Reintuba\u00e7\u00e3o p\u00f3s-cirurgia \u2014 modelagem<\/td><td>Rede neural multicamada (MLP)<\/td><td>Coorte pedi\u00e1trica p\u00f3s-CEC<\/td><td><span class=\"status-badge s-medio\">\u2192 emergente<\/span><\/td><\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div class=\"science-box\">\n<h4>O n\u00famero que muda a leitura da tabela<\/h4>\n<p>Repare nas duas \u00faltimas linhas de AKI. A sensibilidade cai de <strong>0,84 na valida\u00e7\u00e3o interna para 0,70 na valida\u00e7\u00e3o externa<\/strong>. Traduzindo para o ch\u00e3o da UTI: um modelo que \u201cpega\u201d 84 de cada 100 crian\u00e7as que v\u00e3o evoluir com les\u00e3o renal na casa onde foi treinado pode passar a perder cerca de 30 de cada 100 quando roda numa popula\u00e7\u00e3o diferente da nossa \u2014 outro perfusato, outro tempo de CEC, outro case-mix. Isso n\u00e3o \u00e9 defeito do m\u00e9todo; \u00e9 a assinatura do <strong>overfitting populacional<\/strong>. E \u00e9 exatamente o dado que quase nenhum divulgador mostra, porque estraga a manchete.<\/p>\n<\/div>\n<\/section>\n<div class=\"divider\"><\/div>\n<section class=\"section\" id=\"armadilha-pt\">\n<h2 class=\"section-title\">A Armadilha da Valida\u00e7\u00e3o Externa<\/h2>\n<div class=\"detailed-section\">\n<p>Por que um modelo excelente \u201cem casa\u201d trope\u00e7a l\u00e1 fora? Porque ele aprendeu n\u00e3o s\u00f3 o sinal fisiol\u00f3gico universal, mas tamb\u00e9m os <strong>maneirismos do servi\u00e7o onde nasceu<\/strong>: o protocolo de prote\u00e7\u00e3o mioc\u00e1rdica daquela equipe, a curva de temperatura da CEC daquele centro, o limiar de titula\u00e7\u00e3o de inotr\u00f3pico daquele plant\u00e3o, at\u00e9 vieses de registro no prontu\u00e1rio local. Nada disso viaja bem. Quando o algoritmo chega a uma UTI brasileira do SUS, com outra distribui\u00e7\u00e3o de gravidade e outros recursos, a fronteira de decis\u00e3o que ele tra\u00e7ou simplesmente n\u00e3o \u00e9 mais a fronteira correta.<\/p>\n<\/div>\n<div class=\"alert-box\">\n<h4>\u26a0 Um modelo importado sem calibra\u00e7\u00e3o \u00e9 uma decis\u00e3o cl\u00ednica n\u00e3o auditada<\/h4>\n<p>Rodar em produ\u00e7\u00e3o um escore de risco treinado em outro pa\u00eds, confiando no AUC publicado, equivale a titular droga vasoativa por uma refer\u00eancia que voc\u00ea nunca conferiu na sua pr\u00f3pria popula\u00e7\u00e3o. Se a sensibilidade externa \u00e9 0,70, o sistema vai <strong>tranquilizar falsamente<\/strong> em quase 1 de cada 3 crian\u00e7as que iam complicar. Na UTI, falso negativo de deteriora\u00e7\u00e3o n\u00e3o \u00e9 erro estat\u00edstico \u2014 \u00e9 crian\u00e7a que n\u00e3o recebeu a vigil\u00e2ncia extra a tempo.<\/p>\n<\/div>\n<div class=\"highlight-box\">\n<h4>Um exemplo concreto: os 14 beb\u00eas invis\u00edveis<\/h4>\n<p>Pense em 100 crian\u00e7as que <em>de fato<\/em> v\u00e3o desenvolver les\u00e3o renal depois da cirurgia. No hospital onde o modelo nasceu, ele identifica 84 delas a tempo (sensibilidade 0,84) \u2014 excelente. Agora rode o mesmo modelo, sem nenhum ajuste, numa UTI brasileira: ele passa a identificar s\u00f3 70 (sensibilidade 0,70). S\u00e3o <strong>14 crian\u00e7as em cada 100<\/strong> que o sistema rotulou como \u201ctranquilas\u201d e que, na verdade, iam complicar. \u00c9 como um detector de fuma\u00e7a regulado para o ar seco de outro pa\u00eds: continua apitando, mas deixa passar justamente os inc\u00eandios com a cara da sua casa.<\/p>\n<\/div>\n<\/section>\n<div class=\"divider\"><\/div>\n<section class=\"section\" id=\"recalib-pt\">\n<h2 class=\"section-title\">Recalibra\u00e7\u00e3o Local Como Ato Cl\u00ednico<\/h2>\n<div class=\"detailed-section\">\n<p>A boa not\u00edcia: n\u00e3o \u00e9 preciso jogar o modelo fora, nem retreinar do zero. Um modelo externo costuma manter <strong>boa discrimina\u00e7\u00e3o<\/strong> (ordena bem o risco) mesmo quando perde <strong>calibra\u00e7\u00e3o<\/strong> (a probabilidade prevista deixa de bater com a incid\u00eancia real). Existe um trabalho t\u00e9cnico, de baixo custo de dados, que ajusta a sa\u00edda do modelo \u00e0 sua popula\u00e7\u00e3o: a recalibra\u00e7\u00e3o local, via t\u00e9cnicas como <em>Platt scaling<\/em> ou regress\u00e3o isot\u00f4nica, usando algumas centenas de casos do pr\u00f3prio servi\u00e7o, com desfecho conhecido.<\/p>\n<h4>O novo trabalho do m\u00e9dico-desenvolvedor<\/h4>\n<p>Esse passo transforma um modelo de artigo em uma ferramenta confi\u00e1vel na sua unidade \u2014 e ele \u00e9, em ess\u00eancia, um ato cl\u00ednico, n\u00e3o apenas de engenharia. Decidir quantos casos locais coletar, qual desfecho ancorar, com que frequ\u00eancia revisar a calibra\u00e7\u00e3o diante de mudan\u00e7as no perfil dos pacientes (o chamado <em>drift<\/em>): tudo isso exige julgamento de quem conhece a UTI, n\u00e3o s\u00f3 quem conhece Python. \u00c9 aqui que o intensivista que tamb\u00e9m programa deixa de ser consumidor passivo e vira curador do pr\u00f3prio risco.<\/p>\n<\/div>\n<div class=\"highlight-box\">\n<h4>O ciclo m\u00ednimo de recalibra\u00e7\u00e3o<\/h4>\n<ul>\n<li><strong>Importar<\/strong> o modelo externo como caixa-preta de score, sem retreinar.<\/li>\n<li><strong>Coletar<\/strong> uma janela de casos locais com desfecho confirmado (LCOS, AKI ou reintuba\u00e7\u00e3o).<\/li>\n<li><strong>Ajustar<\/strong> uma camada de calibra\u00e7\u00e3o \u00e0 incid\u00eancia real da sua popula\u00e7\u00e3o.<\/li>\n<li><strong>Monitorar<\/strong> o <em>Brier score<\/em> periodicamente para detectar <em>drift<\/em> e disparar nova recalibra\u00e7\u00e3o. <em>(Brier score \u00e9 uma nota de 0 a 1 que mede o qu\u00e3o perto a probabilidade prevista fica do que de fato aconteceu \u2014 quanto menor, melhor; \u00e9 o term\u00f4metro da calibra\u00e7\u00e3o.)<\/em><\/li>\n<\/ul>\n<\/div>\n<div class=\"science-box\">\n<h4>Calibra\u00e7\u00e3o conserta probabilidade \u2014 n\u00e3o conserta discrimina\u00e7\u00e3o ruim<\/h4>\n<p>Um alerta t\u00e9cnico honesto: se o modelo externo j\u00e1 <strong>ordena mal<\/strong> o risco na sua popula\u00e7\u00e3o \u2014 se ele confunde quem complica com quem n\u00e3o complica \u2014, recalibrar n\u00e3o salva. Calibra\u00e7\u00e3o ajusta a escala de probabilidade; ela n\u00e3o cria capacidade discriminativa que o modelo n\u00e3o tem. Nesse caso, o caminho \u00e9 retreino com dados locais ou outro modelo. Saber diferenciar \u201ccalibra\u00e7\u00e3o ruim\u201d de \u201cdiscrimina\u00e7\u00e3o ruim\u201d \u00e9 o que separa o ajuste fino do autoengano.<\/p>\n<\/div>\n<div class=\"highlight-box\">\n<h4>Um exemplo concreto: recalibrar \u00e9 \u201czerar a balan\u00e7a\u201d<\/h4>\n<p>Recalibrar n\u00e3o \u00e9 reconstruir o modelo \u2014 \u00e9 acertar a escala. Pense no glicos\u00edmetro de ponta de dedo que voc\u00ea confere contra a glicemia do laborat\u00f3rio: o aparelho continua o mesmo, voc\u00ea s\u00f3 ajusta a leitura para bater com a realidade. Na recalibra\u00e7\u00e3o \u00e9 igual: voc\u00ea pega algumas centenas de casos da sua pr\u00f3pria UTI, com o desfecho j\u00e1 conhecido, e reajusta a probabilidade que o modelo devolve. O \u201c68% de risco\u201d que valia para Boston vira o \u201c68% de risco\u201d que realmente corresponde \u00e0 incid\u00eancia da sua popula\u00e7\u00e3o. Baixo custo de dados, ganho enorme de confian\u00e7a.<\/p>\n<\/div>\n<\/section>\n<div class=\"divider\"><\/div>\n<section class=\"section\" id=\"cfm-pt\">\n<h2 class=\"section-title\">A Camada Regulat\u00f3ria \u2014 CFM 2.454<\/h2>\n<div class=\"detailed-section\">\n<p>H\u00e1 ainda uma camada que muitos servi\u00e7os esquecem ao brincar com predi\u00e7\u00e3o: a regulat\u00f3ria. A Resolu\u00e7\u00e3o CFM n\u00ba 2.454\/2026 classifica sistemas de IA por n\u00edvel de risco \u2014 baixo, m\u00e9dio, alto ou inaceit\u00e1vel \u2014 considerando impacto em direitos fundamentais, autonomia do modelo e sensibilidade dos dados. Um sistema que prediz desfecho grave em crian\u00e7a p\u00f3s-cir\u00fargica, com potencial de alterar conduta de vigil\u00e2ncia e escalonamento de suporte, dificilmente escapa da categoria de <strong>risco alto<\/strong>.<\/p>\n<h4>O que isso exige na pr\u00e1tica<\/h4>\n<p>Para sistemas de risco alto, a norma pede valida\u00e7\u00e3o documentada, supervis\u00e3o m\u00e9dica sobre a sa\u00edda do modelo e \u2014 ponto cr\u00edtico \u2014 <strong>registro em prontu\u00e1rio sempre que a IA apoiar a decis\u00e3o cl\u00ednica<\/strong>. Ou seja: aquele modelo de AKI recalibrado n\u00e3o entra como piloto autom\u00e1tico; entra como copiloto audit\u00e1vel, cuja recomenda\u00e7\u00e3o e cujo uso ficam rastre\u00e1veis. A vig\u00eancia plena da resolu\u00e7\u00e3o se aproxima, e a obriga\u00e7\u00e3o de classificar o risco \u00e9 da institui\u00e7\u00e3o que implementa, n\u00e3o do fornecedor.<\/p>\n<\/div>\n<\/section>\n<div class=\"divider\"><\/div>\n<section class=\"section\" id=\"tl-pt\">\n<h2 class=\"section-title\">A Linha do Tempo<\/h2>\n<div class=\"flow-box\">\n<h4>Do modelo de paper \u00e0 ferramenta confi\u00e1vel na sua UTI<\/h4>\n<p class=\"flow-intro\">Por que o trabalho real de IA preditiva no p\u00f3s-op card\u00edaco pedi\u00e1trico n\u00e3o termina no download do modelo \u2014 come\u00e7a nele.<\/p>\n<div class=\"flow-steps\">\n<div class=\"flow-step\">\n<div class=\"step-label\">Publica\u00e7\u00e3o<\/div>\n<div class=\"step-title\">Modelo com AUC alto<\/div>\n<div class=\"step-desc\">Valida\u00e7\u00e3o interna reluzente (ex.: AKI Sens 0,84 \/ Espec 0,95). A manchete que circula.<\/div>\n<\/div>\n<div class=\"flow-arrow\">\u279c<\/div>\n<div class=\"flow-step\">\n<div class=\"step-label\">Realidade<\/div>\n<div class=\"step-title\">Queda na valida\u00e7\u00e3o externa<\/div>\n<div class=\"step-desc\">Sensibilidade cai para ~0,70 em outra popula\u00e7\u00e3o. Overfitting ao servi\u00e7o de origem.<\/div>\n<\/div>\n<div class=\"flow-arrow\">\u279c<\/div>\n<div class=\"flow-step current\">\n<div class=\"step-label\">Hoje \u00b7 Voc\u00ea est\u00e1 aqui<\/div>\n<div class=\"step-title\">Recalibra\u00e7\u00e3o local<\/div>\n<div class=\"step-desc\">Ajuste da sa\u00edda \u00e0 incid\u00eancia da sua UTI, com poucas centenas de casos e monitoramento de drift.<\/div>\n<\/div>\n<div class=\"flow-arrow\">\u279c<\/div>\n<div class=\"flow-step\">\n<div class=\"step-label\">Deploy<\/div>\n<div class=\"step-title\">Copiloto audit\u00e1vel (CFM 2.454)<\/div>\n<div class=\"step-desc\">Sistema de risco alto: supervis\u00e3o m\u00e9dica, valida\u00e7\u00e3o documentada e registro em prontu\u00e1rio.<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<div class=\"divider\"><\/div>\n<section class=\"section\" id=\"fazer-pt\">\n<h2 class=\"section-title\">O Que Fazer na Segunda-Feira<\/h2>\n<div class=\"highlight-box\">\n<h4>Da leitura cr\u00edtica ao uso respons\u00e1vel de um modelo preditivo<\/h4>\n<div class=\"checklist-section\">\n<div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>Antes de confiar em qualquer AUC, pergunte se \u00e9 interna ou externa.<\/strong> Se o artigo n\u00e3o reportar valida\u00e7\u00e3o externa, trate o n\u00famero como teto otimista, n\u00e3o como desempenho esperado na sua UTI.<\/div><\/div>\n<div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>Compare cabe\u00e7a a cabe\u00e7a com o escore que voc\u00ea j\u00e1 usa<\/strong> (RACHS-1, VIS) na sua pr\u00f3pria popula\u00e7\u00e3o antes de trocar de ferramenta.<\/div><\/div>\n<div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>Reserve uma janela de casos locais<\/strong> com desfecho confirmado para recalibrar antes de colocar o modelo em produ\u00e7\u00e3o.<\/div><\/div>\n<div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>Monitore o drift<\/strong>: um <em>Brier score<\/em> que sobe m\u00eas a m\u00eas \u00e9 sinal de que a popula\u00e7\u00e3o mudou e a calibra\u00e7\u00e3o venceu.<\/div><\/div>\n<div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>Classifique o sistema pela CFM 2.454<\/strong> e garanta registro em prontu\u00e1rio do uso \u2014 predi\u00e7\u00e3o de desfecho grave tende a ser risco alto.<\/div><\/div>\n<\/div>\n<\/div>\n<\/section>\n<div class=\"cta-section\">\n<h2>Aprenda a Construir IA Preditiva Que Sobrevive \u00e0 Sua UTI<\/h2>\n<p>A metodologia AIMED forma m\u00e9dicos que constroem \u2014 n\u00e3o s\u00f3 usam \u2014 ferramentas de IA cl\u00ednica com rigor cr\u00edtico, valida\u00e7\u00e3o local e consci\u00eancia regulat\u00f3ria desde a arquitetura. Recalibra\u00e7\u00e3o, monitoramento de drift e rastreabilidade CFM 2.454 fazem parte do curr\u00edculo.<\/p>\n<a href=\"https:\/\/inovamed.pro\/?page_id=96\" class=\"cta-button\">Conhe\u00e7a o AIMED \u2192<\/a>\n<\/div>\n<section class=\"section\" id=\"final-pt\">\n<h2 class=\"section-title\">Considera\u00e7\u00f5es Finais<\/h2>\n<div class=\"intro-box\">\n<p>Modelos de machine learning j\u00e1 antecipam baixo d\u00e9bito, les\u00e3o renal e reintuba\u00e7\u00e3o no p\u00f3s-operat\u00f3rio card\u00edaco pedi\u00e1trico com desempenho que impressiona no papel. Mas o AUC bonito da valida\u00e7\u00e3o interna \u00e9 uma promessa, n\u00e3o uma garantia \u2014 e a queda de sensibilidade l\u00e1 fora prova que nenhum modelo \u00e9 <em>plug-and-play<\/em> na beira do leito de uma UTI diferente da que o gerou.<\/p>\n<p>A pergunta que importa n\u00e3o \u00e9 \u201cesse modelo \u00e9 bom?\u201d, e sim \u201cesse modelo \u00e9 bom <em>na minha popula\u00e7\u00e3o<\/em>, e eu tenho como provar isso?\u201d. Responder a ela \u00e9 o novo ato cl\u00ednico da era da IA preditiva.<\/p>\n<p>\ud83d\udca1 <strong>Connecting the Dots:<\/strong> o ativo de autoridade aqui n\u00e3o \u00e9 nenhum dos AUCs \u2014 \u00e9 o gap 0,84 \u2192 0,70 na valida\u00e7\u00e3o externa. Todo mundo posta o n\u00famero bonito; quase ningu\u00e9m no meio m\u00e9dico brasileiro traduz que <em>isso \u00e9 a raz\u00e3o pela qual importar modelo pronto \u00e9 perigoso e calibrar localmente \u00e9 o novo ato cl\u00ednico<\/em>. Essa leitura posiciona o intensivista-desenvolvedor numa terra de ningu\u00e9m rent\u00e1vel: nem o m\u00e9dico que teme IA, nem o entusiasta que engole AUC de abstract \u2014 mas quem sabe que o trabalho real come\u00e7a <em>depois<\/em> do download do modelo. \u00c9 esse discernimento, e n\u00e3o o acesso ao modelo, que vira o verdadeiro fosso t\u00e9cnico de uma ferramenta preditiva feita no Brasil, para a popula\u00e7\u00e3o brasileira.<\/p>\n<\/div>\n<\/section>\n<section class=\"section\" id=\"ref-pt\">\n<div class=\"reference-box\">\n<h4>Refer\u00eancias<\/h4>\n<ol>\n<li>Baloglu O, et al. <em>Supervised Machine Learning Models Predicting Postoperative Low Cardiac Output Syndrome in Neonates<\/em>. Crit Care Explor. 2025 Oct;7(10):e1327. (n=181; 14,9% LCOS; AUROC 0,91\u20130,98; AUPRC 0,60\u20130,80 nos horizontes de 2\u201312 h) Dispon\u00edvel em: https:\/\/doi.org\/10.1097\/CCE.0000000000001327<\/li>\n<li><em>Machine learning models for predicting postoperative acute kidney injury in pediatric cardiac surgery: a systematic review and meta-analysis<\/em>. Front Cardiovasc Med. 2026. Dispon\u00edvel em: https:\/\/www.frontiersin.org\/journals\/cardiovascular-medicine\/articles\/10.3389\/fcvm.2026.1808152\/full<\/li>\n<li>Tong CZ, et al. <em>Machine learning prediction model of major adverse outcomes after pediatric congenital heart surgery: a retrospective cohort study<\/em>. Int J Surg. 2024. (23.000 pacientes; LCOS na coorte de teste: LightGBM AUC 0,893, IC95% 0,884\u20130,895) Dispon\u00edvel em: https:\/\/pubmed.ncbi.nlm.nih.gov\/38265429\/<\/li>\n<li><em>The application of machine learning in predicting post-cardiac surgery acute kidney injury in pediatric patients: a systematic review<\/em>. PMC. Dispon\u00edvel em: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12378388\/<\/li>\n<li><em>Artificial Intelligence in Pediatric Cardiac Intensive Care: Clinical Applications, Implementation Challenges, and Future Directions<\/em>. Curr Treat Options Pediatr. 2026. Dispon\u00edvel em: https:\/\/link.springer.com\/article\/10.1007\/s40746-026-00374-8<\/li>\n<li>Conselho Federal de Medicina. <em>Resolu\u00e7\u00e3o CFM n\u00ba 2.454, de 11 de fevereiro de 2026<\/em>. DOU 2026 fev 27; Ed. 39, Se\u00e7\u00e3o 1. Dispon\u00edvel em: https:\/\/sistemas.cfm.org.br\/normas\/arquivos\/resolucoes\/BR\/2026\/2454_2026.pdf<\/li>\n<\/ol>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<!-- ===================== CONTE\u00daDO EN ===================== -->\n<div id=\"content-en\" class=\"hidden\">\n<section class=\"hero\" id=\"top-en\">\n<span class=\"article-tag\">Pediatric Cardiology \u00b7 Machine Learning \u00b7 ICU<\/span>\n<h1>The AI That Predicts Pediatric Cardiac Complications \u2014 and the Trap No One Shows You<\/h1>\n<p class=\"subtitle\">The recent wave brought machine learning models that anticipate low cardiac output, acute kidney injury, and reintubation after pediatric cardiac surgery with AUC near 0.90 \u2014 that is, given two children, they almost always identify which one carries the higher risk of deteriorating, beating many classic scores. But there is a number almost no post displays: away from the hospital where they were born, sensitivity \u2014 the share of at-risk children the model actually catches \u2014 plunges. Understanding that drop is what separates importing a paper model from building a tool that survives your ICU.<\/p>\n<p class=\"meta-info\">Dr. Mbula Luzingu Barros | Pediatric Intensivist \u00b7 25 years in Pediatric ICU | AI Healthcare Consultant | Founder of INOVAMED | Creator of the AIMED Methodology<\/p>\n<p class=\"date\">\ud83d\udcc5 Published July 22, 2026<\/p>\n<div class=\"deadline-badge\">\u23f1 CFM 2.454 full enforcement in: <span class=\"countdown-days\">35<\/span> days \u2014 August 26, 2026<\/div>\n<\/section>\n<div class=\"container\">\n<nav class=\"toc\" id=\"indice-en\">\n<h2>Table of Contents<\/h2>\n<p class=\"toc-subtitle\">From the bedside outcome to local recalibration \u2014 the clinical work that begins after you download the model<\/p>\n<ul>\n<li><a href=\"#ctx-en\">1. Why This Matters for Those on the Front Line<\/a><\/li>\n<li><a href=\"#safra-en\">2. What the Recent Wave Delivered<\/a><\/li>\n<li><a href=\"#num-en\">3. The Numbers, Unfiltered<\/a><\/li>\n<li><a href=\"#armadilha-en\">4. The External-Validation Trap<\/a><\/li>\n<li><a href=\"#recalib-en\">5. Local Recalibration as a Clinical Act<\/a><\/li>\n<li><a href=\"#cfm-en\">6. The Regulatory Layer \u2014 CFM 2.454<\/a><\/li>\n<li><a href=\"#tl-en\">7. The Timeline<\/a><\/li>\n<li><a href=\"#fazer-en\">8. What to Do on Monday<\/a><\/li>\n<li><a href=\"#final-en\">9. Final Considerations<\/a><\/li>\n<li><a href=\"#ref-en\">10. References<\/a><\/li>\n<\/ul>\n<\/nav>\n<section class=\"section\" id=\"ctx-en\">\n<h2 class=\"section-title\">Why This Matters for Those on the Front Line<\/h2>\n<div class=\"intro-box\">\n<p>The postoperative period of congenital cardiac surgery is one of the tensest windows in the pediatric ICU. Three shadows loom over the first week: <strong>low cardiac output syndrome<\/strong> (LCOS), <strong>acute kidney injury<\/strong> (AKI) linked to cardiopulmonary bypass, and <strong>reintubation<\/strong> after a wean that seemed safe. These are outcomes we learn to sense over years on call \u2014 a subtle shift in perfusion, in lactate, in urine output.<\/p>\n<p>In recent years, a consistent wave of machine learning models began anticipating exactly these three complications, with performance that, on paper, beats much of the traditional scoring we still use at the bedside. The promise is seductive: a system that flags risk hours ahead of the trained eye. But there is a technical detail \u2014 <strong>invisible to anyone reading only the abstract<\/strong> \u2014 that decides whether that model helps or harms in your unit. That is what this article dwells on.<\/p>\n<\/div>\n<\/section>\n<div class=\"divider\"><\/div>\n<section class=\"section\" id=\"safra-en\">\n<h2 class=\"section-title\">What the Recent Wave Delivered<\/h2>\n<div class=\"detailed-section\">\n<p>The recent models tackle the three outcomes head-on. For <strong>low cardiac output in neonates<\/strong>, a recent study trained gradient-boosting models (LightGBM) on a cohort of 181 neonates, 14.9% of whom developed LCOS, reaching AUROC values of 0.91 to 0.98 depending on the forecasting horizon (2 to 12 hours ahead). For the same syndrome in a broader pediatric population, another LightGBM model achieved an AUC of 0.893. The predictors the algorithms selected surprise no intensivist: a high vasoactive-inotropic score (VIS), low urine output, and high serum lactate in the neonatal model; and mechanical ventilation time as the leading contributor in the larger pediatric model.<\/p>\n<h4>Kidney injury and reintubation<\/h4>\n<p>For <strong>post-bypass AKI<\/strong>, a 2026 meta-analysis pooled seven studies totaling nearly 12,000 children and found a pooled (SROC) AUC of 0.91. For <strong>reintubation<\/strong>, a multilayer neural network modeled one of the most frustrating bottlenecks of postoperative weaning. The quantitative message is coherent: in discrimination, these models beat scores like RACHS-1 alone and rival experienced clinical judgment.<\/p>\n<\/div>\n<div class=\"warning-box\">\n<h4>\u26a0 Good discrimination is not the same as clinical trust<\/h4>\n<p>An AUC of 0.91 says the model <strong>ranks risk well<\/strong> \u2014 it orders who is more and less likely to deteriorate. It does not say that the <strong>absolute probability<\/strong> it outputs (\u201c68% chance of AKI\u201d) matches your population&#8217;s reality. And, crucially, the shiny number almost always comes from internal validation \u2014 the model tested in the same house where it was born. Its behavior away from home is another story.<\/p>\n<\/div>\n<div class=\"highlight-box\">\n<h4>A concrete example: what \u201cpredicting\u201d means here<\/h4>\n<p>Picture a newborn who has just come out of Norwood surgery and reaches the ICU at two in the morning. On the monitor, everything still looks stable. In the background, the model reads the same variables you would \u2014 lactate, urine output, inotrope dose, cardiopulmonary bypass time \u2014 and returns a signal: <strong>\u201chigh risk of kidney injury in the next 24 hours.\u201d<\/strong> In practice this doesn&#8217;t change the diagnosis; it changes the <em>vigilance<\/em>. You draw creatinine earlier, hold a nephrotoxic drug, ask nursing to time urine output hourly. The model decides nothing \u2014 it points to where your eye should land first.<\/p>\n<\/div>\n<\/section>\n<div class=\"divider\"><\/div>\n<section class=\"section\" id=\"num-en\">\n<h2 class=\"section-title\">The Numbers, Unfiltered<\/h2>\n<p style=\"font-size:clamp(1rem,2.5vw,1.1rem);line-height:1.9;text-align:justify;margin-bottom:8px;\">Before reading the table, keep three acronyms on the tip of your tongue. They sound dry, but each answers a question you already ask in your head on call \u2014 just without the technical name.<\/p>\n<div class=\"science-box\">\n<h4>The acronym decoder (keep these three)<\/h4>\n<p><strong>AUC (or AUROC) \u2014 \u201ccan the model rank risk?\u201d<\/strong> Imagine drawing two children at random, one who will deteriorate and one who won&#8217;t. The AUC is the probability the model gives the higher risk score to the one who actually deteriorates. <strong>0.50 is a coin flip<\/strong> (useless), <strong>1.00 is perfection<\/strong>, and <strong>0.90 means it wins that bet 9 times out of 10<\/strong>. Note: it&#8217;s a score of <em>ranking<\/em> between patients \u2014 not a certainty about any single patient.<\/p>\n<p><strong>Sensitivity \u2014 \u201cof those who would deteriorate, how many does it catch?\u201d<\/strong> Sensitivity 0.84 means that, of 100 children who really will deteriorate, the model raises the alert on 84; the other 16 slip by (the false negatives). In the ICU, this is the metric that hurts most to miss \u2014 a child who deteriorates without extra vigilance.<\/p>\n<p><strong>Specificity \u2014 \u201cof those who were fine, how many does it leave alone?\u201d<\/strong> Specificity 0.95 means that, of 100 children who will <em>not<\/em> deteriorate, only 5 get a needless alarm (the false positives). Low specificity is the mother of <em>alarm fatigue<\/em>: the monitor that screams so much no one listens anymore.<\/p>\n<p><strong>And AUPRC?<\/strong> It&#8217;s the AUC&#8217;s cousin, but honest when the event is <em>rare<\/em>. When only 1 in 20 children deteriorates, the AUC can look deceptively beautiful; the AUPRC won&#8217;t let it slide. That&#8217;s why the neonatal LCOS study reports both (AUROC 0.91\u20130.98 and AUPRC 0.60\u20130.80) \u2014 the second is the first one&#8217;s reality check.<\/p>\n<\/div>\n<div class=\"table-wrapper\">\n<table class=\"data-table\">\n<thead>\n<tr>\n<th>Reference<\/th>\n<th>Outcome \/ Variable<\/th>\n<th>Value<\/th>\n<th>Source<\/th>\n<th>Reading<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr><td>2025<\/td><td>Neonatal LCOS \u2014 AUROC<\/td><td>0.91\u20130.98 (AUPRC 0.60\u20130.80; n=181; 14.9% LCOS)<\/td><td>Baloglu et al. \u00b7 Crit Care Explor<\/td><td><span class=\"status-badge s-medio\">\u2191 good<\/span><\/td><\/tr>\n<tr><td>2024<\/td><td>Pediatric LCOS \u2014 AUC (LightGBM)<\/td><td>0.893 (95% CI 0.884\u20130.895)<\/td><td>Retrospective cohort \u00b7 Int J Surg<\/td><td><span class=\"status-badge s-medio\">\u2191 good<\/span><\/td><\/tr>\n<tr><td>2026<\/td><td>Post-bypass AKI \u2014 pooled AUC (SROC)<\/td><td>0.91 (95% CI 0.88\u20130.93; 7 studies; ~12,000 children)<\/td><td>Meta-analysis \u00b7 Front Cardiovasc Med<\/td><td><span class=\"status-badge s-medio\">\u2191 good<\/span><\/td><\/tr>\n<tr><td>2026<\/td><td>AKI \u2014 <em>internal<\/em> validation (Sens \/ Spec)<\/td><td>0.84 \/ 0.95<\/td><td>Meta-analysis \u00b7 Front Cardiovasc Med<\/td><td><span class=\"status-badge s-baixo\">\u2191 excellent (at home)<\/span><\/td><\/tr>\n<tr><td>2026<\/td><td>AKI \u2014 <em>external<\/em> validation (Sens \/ Spec)<\/td><td>0.70 \/ 0.80<\/td><td>Meta-analysis \u00b7 Front Cardiovasc Med<\/td><td><span class=\"status-badge s-alto\">\u2193 drops away from home<\/span><\/td><\/tr>\n<tr><td>2026<\/td><td>Post-surgical reintubation \u2014 modeling<\/td><td>Multilayer neural network (MLP)<\/td><td>Pediatric post-bypass cohort<\/td><td><span class=\"status-badge s-medio\">\u2192 emerging<\/span><\/td><\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<div class=\"science-box\">\n<h4>The number that changes how you read this table<\/h4>\n<p>Look at the two AKI validation rows. Sensitivity drops from <strong>0.84 on internal validation to 0.70 on external validation<\/strong>. Translated to the ICU floor: a model that \u201ccatches\u201d 84 of every 100 children who will develop kidney injury in the house where it was trained may start missing about 30 of every 100 when run on a population different from ours \u2014 another priming solution, another bypass time, another case-mix. This is not a flaw in the method; it is the signature of <strong>population overfitting<\/strong>. And it is exactly the data almost no popularizer shows, because it ruins the headline.<\/p>\n<\/div>\n<\/section>\n<div class=\"divider\"><\/div>\n<section class=\"section\" id=\"armadilha-en\">\n<h2 class=\"section-title\">The External-Validation Trap<\/h2>\n<div class=\"detailed-section\">\n<p>Why does a model that is excellent \u201cat home\u201d stumble elsewhere? Because it learned not only the universal physiological signal but also the <strong>mannerisms of the service where it was born<\/strong>: that team&#8217;s myocardial protection protocol, that center&#8217;s bypass temperature curve, that shift&#8217;s inotrope titration threshold, even local charting biases. None of that travels well. When the algorithm reaches a Brazilian public-system ICU, with a different severity distribution and different resources, the decision boundary it drew is simply no longer the correct one.<\/p>\n<\/div>\n<div class=\"alert-box\">\n<h4>\u26a0 An imported model without calibration is an unaudited clinical decision<\/h4>\n<p>Running a risk score trained in another country in production, trusting the published AUC, is like titrating a vasoactive drug by a reference you never checked in your own population. If external sensitivity is 0.70, the system will <strong>falsely reassure<\/strong> in nearly 1 of every 3 children who were going to deteriorate. In the ICU, a false-negative for deterioration is not a statistical error \u2014 it is a child who did not get the extra vigilance in time.<\/p>\n<\/div>\n<div class=\"highlight-box\">\n<h4>A concrete example: the 14 invisible babies<\/h4>\n<p>Think of 100 children who will <em>actually<\/em> develop kidney injury after surgery. In the hospital where the model was born, it flags 84 of them in time (sensitivity 0.84) \u2014 excellent. Now run the same model, with no adjustment, in a Brazilian ICU: it now flags only 70 (sensitivity 0.70). That is <strong>14 children in every 100<\/strong> the system labeled \u201cfine\u201d who were, in fact, going to deteriorate. It&#8217;s like a smoke detector tuned for another country&#8217;s dry air: it still beeps, but it lets through exactly the fires that look like your house.<\/p>\n<\/div>\n<\/section>\n<div class=\"divider\"><\/div>\n<section class=\"section\" id=\"recalib-en\">\n<h2 class=\"section-title\">Local Recalibration as a Clinical Act<\/h2>\n<div class=\"detailed-section\">\n<p>The good news: you don&#8217;t have to throw the model away or retrain from scratch. An external model usually keeps <strong>good discrimination<\/strong> (it ranks risk well) even when it loses <strong>calibration<\/strong> (the predicted probability no longer matches real incidence). There is a technical, low-data-cost step that fits the model&#8217;s output to your population: local recalibration, via techniques like <em>Platt scaling<\/em> or isotonic regression, using a few hundred of your own cases with known outcomes.<\/p>\n<h4>The new work of the physician-developer<\/h4>\n<p>This step turns a paper model into a tool you can trust in your unit \u2014 and it is, in essence, a clinical act, not merely an engineering one. Deciding how many local cases to collect, which outcome to anchor, how often to review calibration as the patient profile changes (so-called <em>drift<\/em>): all of this demands the judgment of someone who knows the ICU, not just Python. This is where the intensivist who also codes stops being a passive consumer and becomes the curator of their own risk.<\/p>\n<\/div>\n<div class=\"highlight-box\">\n<h4>The minimal recalibration cycle<\/h4>\n<ul>\n<li><strong>Import<\/strong> the external model as a black-box score, without retraining.<\/li>\n<li><strong>Collect<\/strong> a window of local cases with confirmed outcome (LCOS, AKI, or reintubation).<\/li>\n<li><strong>Fit<\/strong> a calibration layer to your population&#8217;s real incidence.<\/li>\n<li><strong>Monitor<\/strong> the <em>Brier score<\/em> periodically to detect <em>drift<\/em> and trigger recalibration. <em>(The Brier score is a 0-to-1 grade of how close the predicted probability sits to what actually happened \u2014 lower is better; it&#8217;s the thermometer of calibration.)<\/em><\/li>\n<\/ul>\n<\/div>\n<div class=\"science-box\">\n<h4>Calibration fixes probability \u2014 it does not fix poor discrimination<\/h4>\n<p>An honest technical caveat: if the external model already <strong>ranks risk poorly<\/strong> in your population \u2014 if it confuses who deteriorates with who doesn&#8217;t \u2014 recalibration won&#8217;t save it. Calibration adjusts the probability scale; it does not create discriminative power the model lacks. In that case, the path is retraining with local data or a different model. Knowing how to tell \u201cpoor calibration\u201d from \u201cpoor discrimination\u201d is what separates fine-tuning from self-deception.<\/p>\n<\/div>\n<div class=\"highlight-box\">\n<h4>A concrete example: recalibrating is \u201cre-zeroing the scale\u201d<\/h4>\n<p>Recalibrating isn&#8217;t rebuilding the model \u2014 it&#8217;s correcting the scale. Think of the fingertip glucometer you check against the lab glucose: the device stays the same, you just adjust the reading to match reality. Recalibration is the same: you take a few hundred cases from your own ICU, with the outcome already known, and readjust the probability the model returns. The \u201c68% risk\u201d that held for Boston becomes the \u201c68% risk\u201d that truly matches your population&#8217;s incidence. Low data cost, a huge gain in trust.<\/p>\n<\/div>\n<\/section>\n<div class=\"divider\"><\/div>\n<section class=\"section\" id=\"cfm-en\">\n<h2 class=\"section-title\">The Regulatory Layer \u2014 CFM 2.454<\/h2>\n<div class=\"detailed-section\">\n<p>There is one more layer many services forget while playing with prediction: the regulatory one. CFM Resolution No. 2,454\/2026 classifies AI systems by risk level \u2014 low, medium, high, or unacceptable \u2014 considering impact on fundamental rights, model autonomy, and data sensitivity. A system that predicts a serious outcome in a post-surgical child, with the potential to alter surveillance and support-escalation decisions, hardly escapes the <strong>high-risk<\/strong> category.<\/p>\n<h4>What that requires in practice<\/h4>\n<p>For high-risk systems, the norm requires documented validation, physician oversight of the model&#8217;s output, and \u2014 critically \u2014 <strong>a chart entry whenever AI supports the clinical decision<\/strong>. In other words: that recalibrated AKI model does not enter as autopilot; it enters as an auditable copilot, whose recommendation and use remain traceable. Full enforcement of the resolution is approaching, and the duty to classify the risk belongs to the implementing institution, not the vendor.<\/p>\n<\/div>\n<\/section>\n<div class=\"divider\"><\/div>\n<section class=\"section\" id=\"tl-en\">\n<h2 class=\"section-title\">The Timeline<\/h2>\n<div class=\"flow-box\">\n<h4>From paper model to a tool you can trust in your ICU<\/h4>\n<p class=\"flow-intro\">Why the real work of predictive AI in pediatric cardiac postop doesn&#8217;t end when you download the model \u2014 it begins there.<\/p>\n<div class=\"flow-steps\">\n<div class=\"flow-step\">\n<div class=\"step-label\">Publication<\/div>\n<div class=\"step-title\">Model with high AUC<\/div>\n<div class=\"step-desc\">Shiny internal validation (e.g., AKI Sens 0.84 \/ Spec 0.95). The headline that circulates.<\/div>\n<\/div>\n<div class=\"flow-arrow\">\u279c<\/div>\n<div class=\"flow-step\">\n<div class=\"step-label\">Reality<\/div>\n<div class=\"step-title\">Drop on external validation<\/div>\n<div class=\"step-desc\">Sensitivity falls to ~0.70 in another population. Overfitting to the origin service.<\/div>\n<\/div>\n<div class=\"flow-arrow\">\u279c<\/div>\n<div class=\"flow-step current\">\n<div class=\"step-label\">Today \u00b7 You are here<\/div>\n<div class=\"step-title\">Local recalibration<\/div>\n<div class=\"step-desc\">Fitting the output to your ICU&#8217;s incidence, with a few hundred cases and drift monitoring.<\/div>\n<\/div>\n<div class=\"flow-arrow\">\u279c<\/div>\n<div class=\"flow-step\">\n<div class=\"step-label\">Deploy<\/div>\n<div class=\"step-title\">Auditable copilot (CFM 2.454)<\/div>\n<div class=\"step-desc\">High-risk system: physician oversight, documented validation, and a chart entry.<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<div class=\"divider\"><\/div>\n<section class=\"section\" id=\"fazer-en\">\n<h2 class=\"section-title\">What to Do on Monday<\/h2>\n<div class=\"highlight-box\">\n<h4>From critical reading to the responsible use of a predictive model<\/h4>\n<div class=\"checklist-section\">\n<div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>Before trusting any AUC, ask whether it is internal or external.<\/strong> If the paper reports no external validation, treat the number as an optimistic ceiling, not the performance expected in your ICU.<\/div><\/div>\n<div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>Compare head-to-head with the score you already use<\/strong> (RACHS-1, VIS) in your own population before switching tools.<\/div><\/div>\n<div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>Set aside a window of local cases<\/strong> with confirmed outcome to recalibrate before putting the model into production.<\/div><\/div>\n<div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>Monitor drift<\/strong>: a <em>Brier score<\/em> that climbs month over month signals that the population has shifted and calibration has expired.<\/div><\/div>\n<div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>Classify the system under CFM 2.454<\/strong> and ensure a chart entry for its use \u2014 predicting a serious outcome tends to be high risk.<\/div><\/div>\n<\/div>\n<\/div>\n<\/section>\n<div class=\"cta-section\">\n<h2>Learn to Build Predictive AI That Survives Your ICU<\/h2>\n<p>The AIMED methodology trains physicians who build \u2014 not just use \u2014 clinical AI tools with critical rigor, local validation, and regulatory awareness baked into the architecture. Recalibration, drift monitoring, and CFM 2.454 traceability are part of the curriculum.<\/p>\n<a href=\"https:\/\/inovamed.pro\/?page_id=96\" class=\"cta-button\">Discover AIMED \u2192<\/a>\n<\/div>\n<section class=\"section\" id=\"final-en\">\n<h2 class=\"section-title\">Final Considerations<\/h2>\n<div class=\"intro-box\">\n<p>Machine learning models already anticipate low cardiac output, kidney injury, and reintubation after pediatric cardiac surgery with performance that impresses on paper. But the pretty internal-validation AUC is a promise, not a guarantee \u2014 and the sensitivity drop away from home proves that no model is <em>plug-and-play<\/em> at the bedside of an ICU different from the one that produced it.<\/p>\n<p>The question that matters is not \u201cis this model good?\u201d but \u201cis this model good <em>in my population<\/em>, and can I prove it?\u201d. Answering that is the new clinical act of the predictive-AI era.<\/p>\n<p>\ud83d\udca1 <strong>Connecting the Dots:<\/strong> the authority asset here is none of the AUCs \u2014 it is the 0.84 \u2192 0.70 gap on external validation. Everyone posts the pretty number; almost no one in Brazilian medicine translates that <em>this is precisely why importing a ready-made model is dangerous and calibrating locally is the new clinical act<\/em>. That reading places the physician-developer in a profitable no-man&#8217;s-land: neither the doctor who fears AI, nor the enthusiast who swallows abstract AUCs \u2014 but the one who knows the real work begins <em>after<\/em> downloading the model. It is that discernment, not access to the model, that becomes the true technical moat of a predictive tool built in Brazil, for the Brazilian population.<\/p>\n<\/div>\n<\/section>\n<section class=\"section\" id=\"ref-en\">\n<div class=\"reference-box\">\n<h4>References<\/h4>\n<ol>\n<li>Baloglu O, et al. <em>Supervised Machine Learning Models Predicting Postoperative Low Cardiac Output Syndrome in Neonates<\/em>. Crit Care Explor. 2025 Oct;7(10):e1327. (n=181; 14.9% LCOS; AUROC 0.91\u20130.98; AUPRC 0.60\u20130.80 across 2\u201312 h horizons) Available at: https:\/\/doi.org\/10.1097\/CCE.0000000000001327<\/li>\n<li><em>Machine learning models for predicting postoperative acute kidney injury in pediatric cardiac surgery: a systematic review and meta-analysis<\/em>. Front Cardiovasc Med. 2026. Available at: https:\/\/www.frontiersin.org\/journals\/cardiovascular-medicine\/articles\/10.3389\/fcvm.2026.1808152\/full<\/li>\n<li>Tong CZ, et al. <em>Machine learning prediction model of major adverse outcomes after pediatric congenital heart surgery: a retrospective cohort study<\/em>. Int J Surg. 2024. (23,000 patients; LCOS in the test cohort: LightGBM AUC 0.893, 95% CI 0.884\u20130.895) Available at: https:\/\/pubmed.ncbi.nlm.nih.gov\/38265429\/<\/li>\n<li><em>The application of machine learning in predicting post-cardiac surgery acute kidney injury in pediatric patients: a systematic review<\/em>. PMC. Available at: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12378388\/<\/li>\n<li><em>Artificial Intelligence in Pediatric Cardiac Intensive Care: Clinical Applications, Implementation Challenges, and Future Directions<\/em>. Curr Treat Options Pediatr. 2026. Available at: https:\/\/link.springer.com\/article\/10.1007\/s40746-026-00374-8<\/li>\n<li>Federal Council of Medicine (CFM). <em>Resolution CFM No. 2,454, of February 11, 2026<\/em>. Official Gazette 2026 Feb 27; Ed. 39, Sec. 1. Available at: https:\/\/sistemas.cfm.org.br\/normas\/arquivos\/resolucoes\/BR\/2026\/2454_2026.pdf<\/li>\n<\/ol>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<!-- FOOTER -->\n<div class=\"footer\">\n<p><strong>Dr. Mbula Luzingu Barros<\/strong><\/p>\n<p id=\"footer-specialty-pt\">M\u00e9dico Pediatra Intensivista \u00b7 25 anos de UTI | Consultor em IA na Sa\u00fade | Fundador da INOVAMED | Criador da Metodologia AIMED<\/p>\n<p id=\"footer-specialty-en\" class=\"hidden\">Pediatric Intensivist \u00b7 25 years in ICU | AI Healthcare Consultant | Founder of INOVAMED | Creator of the AIMED Methodology<\/p>\n<p style=\"margin-top: 20px; opacity: 0.65; font-size: 0.9rem;\">\u00a9 2026 inovamed.pro \u2014 Este artigo pode ser compartilhado com atribui\u00e7\u00e3o ao autor \u00b7 This article may be shared with attribution to the author<\/p>\n<\/div>\n<script>\nfunction switchLanguage(lang) {\nvar ptC = document.getElementById('content-pt');\nvar enC = document.getElementById('content-en');\nvar btnPt = document.getElementById('btn-pt');\nvar btnEn = document.getElementById('btn-en');\nvar navBtnTop = document.getElementById('nav-btn-top');\nvar navBtnToc = document.getElementById('nav-btn-toc');\nvar footerPt = document.getElementById('footer-specialty-pt');\nvar footerEn = document.getElementById('footer-specialty-en');\nif (lang === 'pt') {\nptC.classList.remove('hidden'); enC.classList.add('hidden');\nbtnPt.classList.add('active'); btnEn.classList.remove('active');\ndocument.documentElement.lang = 'pt-BR';\nnavBtnTop.href = '#top-pt'; navBtnToc.href = '#indice-pt';\nfooterPt.classList.remove('hidden'); footerEn.classList.add('hidden');\n} else {\nptC.classList.add('hidden'); enC.classList.remove('hidden');\nbtnPt.classList.remove('active'); btnEn.classList.add('active');\ndocument.documentElement.lang = 'en';\nnavBtnTop.href = '#top-en'; navBtnToc.href = '#indice-en';\nfooterPt.classList.add('hidden'); footerEn.classList.remove('hidden');\n}\n}\nfunction updateCountdown() {\nvar target = new Date('2026-08-26T00:00:00');\nvar now = new Date();\nvar diff = target - now;\nif (diff > 0) {\nvar days = Math.ceil(diff \/ (1000 * 60 * 60 * 24));\ndocument.querySelectorAll('.countdown-days').forEach(function(el) { el.textContent = days; });\n}\n}\ndocument.addEventListener('DOMContentLoaded', function() {\nswitchLanguage('pt');\nupdateCountdown();\n});\nupdateCountdown();\n<\/script>\n<\/div><p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2191 \ud83e\udded \ud83c\udde7\ud83c\uddf7 PT \ud83c\uddfa\ud83c\uddf8 EN Cardiologia Pedi\u00e1trica \u00b7 Machine Learning \u00b7 UTI A IA Que Prev\u00ea Complica\u00e7\u00e3o Card\u00edaca Infantil \u2014 e a Armadilha Que Ningu\u00e9m Mostra A safra recente trouxe modelos de machine learning que antecipam baixo d\u00e9bito, les\u00e3o renal e reintuba\u00e7\u00e3o no p\u00f3s-operat\u00f3rio card\u00edaco pedi\u00e1trico com AUC perto<span class=\"more-link\"><a href=\"https:\/\/inovamed.pro\/?p=2792\">LEIA O ARTIGO COMPLETO<\/a><\/span><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["entry","author-mbulabarros","post-2792","post","type-post","status-publish","format-standard","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>A IA Que Prev\u00ea Complica\u00e7\u00e3o Card\u00edaca Infantil \u2014 e a Armadilha Que Ningu\u00e9m Mostra - INOVAMED<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/inovamed.pro\/?p=2792\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A IA Que Prev\u00ea Complica\u00e7\u00e3o Card\u00edaca Infantil \u2014 e a Armadilha Que Ningu\u00e9m Mostra - INOVAMED\" \/>\n<meta property=\"og:description\" content=\"\u2191 \ud83e\udded \ud83c\udde7\ud83c\uddf7 PT \ud83c\uddfa\ud83c\uddf8 EN Cardiologia Pedi\u00e1trica \u00b7 Machine Learning \u00b7 UTI A IA Que Prev\u00ea Complica\u00e7\u00e3o Card\u00edaca Infantil \u2014 e a Armadilha Que Ningu\u00e9m Mostra A safra recente trouxe modelos de machine learning que antecipam baixo d\u00e9bito, les\u00e3o renal e reintuba\u00e7\u00e3o no p\u00f3s-operat\u00f3rio card\u00edaco pedi\u00e1trico com AUC pertoLEIA O ARTIGO COMPLETO\" \/>\n<meta property=\"og:url\" content=\"https:\/\/inovamed.pro\/?p=2792\" \/>\n<meta property=\"og:site_name\" content=\"INOVAMED\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-22T23:16:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-22T23:16:50+00:00\" \/>\n<meta name=\"author\" content=\"mbulabarros\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"mbulabarros\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"29 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/inovamed.pro\/?p=2792#article\",\"isPartOf\":{\"@id\":\"https:\/\/inovamed.pro\/?p=2792\"},\"author\":{\"name\":\"mbulabarros\",\"@id\":\"https:\/\/inovamed.pro\/#\/schema\/person\/f023d988086a844cf27e25d0dd97e239\"},\"headline\":\"A IA Que Prev\u00ea Complica\u00e7\u00e3o Card\u00edaca Infantil \u2014 e a Armadilha Que Ningu\u00e9m Mostra\",\"datePublished\":\"2026-07-22T23:16:37+00:00\",\"dateModified\":\"2026-07-22T23:16:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/inovamed.pro\/?p=2792\"},\"wordCount\":5771,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/inovamed.pro\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/inovamed.pro\/?p=2792#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/inovamed.pro\/?p=2792\",\"url\":\"https:\/\/inovamed.pro\/?p=2792\",\"name\":\"A IA Que Prev\u00ea Complica\u00e7\u00e3o Card\u00edaca Infantil \u2014 e a Armadilha Que Ningu\u00e9m Mostra - INOVAMED\",\"isPartOf\":{\"@id\":\"https:\/\/inovamed.pro\/#website\"},\"datePublished\":\"2026-07-22T23:16:37+00:00\",\"dateModified\":\"2026-07-22T23:16:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/inovamed.pro\/?p=2792#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/inovamed.pro\/?p=2792\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/inovamed.pro\/?p=2792#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/inovamed.pro\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A IA Que Prev\u00ea Complica\u00e7\u00e3o Card\u00edaca Infantil \u2014 e a Armadilha Que Ningu\u00e9m Mostra\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/inovamed.pro\/#website\",\"url\":\"https:\/\/inovamed.pro\/\",\"name\":\"INOVAMED\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/inovamed.pro\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/inovamed.pro\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/inovamed.pro\/#organization\",\"name\":\"INOVAMED\",\"url\":\"https:\/\/inovamed.pro\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/inovamed.pro\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/inovamed.pro\/wp-content\/uploads\/2024\/12\/cropped-DALL\u00b7E-2024-12-10-13.53.06-A-hyperrealistic-3D-rendering-of-a-half-human-brain-merged-with-circuit-board-patterns-viewed-from-a-slight-side-angle.-The-brains-left-hemisphere-s.webp\",\"contentUrl\":\"https:\/\/inovamed.pro\/wp-content\/uploads\/2024\/12\/cropped-DALL\u00b7E-2024-12-10-13.53.06-A-hyperrealistic-3D-rendering-of-a-half-human-brain-merged-with-circuit-board-patterns-viewed-from-a-slight-side-angle.-The-brains-left-hemisphere-s.webp\",\"width\":1706,\"height\":1023,\"caption\":\"INOVAMED\"},\"image\":{\"@id\":\"https:\/\/inovamed.pro\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/inovamed.pro\/#\/schema\/person\/f023d988086a844cf27e25d0dd97e239\",\"name\":\"mbulabarros\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/inovamed.pro\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b45ea8fc03f19632f2c0e1180c867958fb387b48b3fe9af6e41ad80bbcf0d3c9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b45ea8fc03f19632f2c0e1180c867958fb387b48b3fe9af6e41ad80bbcf0d3c9?s=96&d=mm&r=g\",\"caption\":\"mbulabarros\"},\"sameAs\":[\"https:\/\/inovamed.pro\"],\"url\":\"https:\/\/inovamed.pro\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A IA Que Prev\u00ea Complica\u00e7\u00e3o Card\u00edaca Infantil \u2014 e a Armadilha Que Ningu\u00e9m Mostra - INOVAMED","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/inovamed.pro\/?p=2792","og_locale":"pt_BR","og_type":"article","og_title":"A IA Que Prev\u00ea Complica\u00e7\u00e3o Card\u00edaca Infantil \u2014 e a Armadilha Que Ningu\u00e9m Mostra - INOVAMED","og_description":"\u2191 \ud83e\udded \ud83c\udde7\ud83c\uddf7 PT \ud83c\uddfa\ud83c\uddf8 EN Cardiologia Pedi\u00e1trica \u00b7 Machine Learning \u00b7 UTI A IA Que Prev\u00ea Complica\u00e7\u00e3o Card\u00edaca Infantil \u2014 e a Armadilha Que Ningu\u00e9m Mostra A safra recente trouxe modelos de machine learning que antecipam baixo d\u00e9bito, les\u00e3o renal e reintuba\u00e7\u00e3o no p\u00f3s-operat\u00f3rio card\u00edaco pedi\u00e1trico com AUC pertoLEIA O ARTIGO COMPLETO","og_url":"https:\/\/inovamed.pro\/?p=2792","og_site_name":"INOVAMED","article_published_time":"2026-07-22T23:16:37+00:00","article_modified_time":"2026-07-22T23:16:50+00:00","author":"mbulabarros","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"mbulabarros","Est. tempo de leitura":"29 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/inovamed.pro\/?p=2792#article","isPartOf":{"@id":"https:\/\/inovamed.pro\/?p=2792"},"author":{"name":"mbulabarros","@id":"https:\/\/inovamed.pro\/#\/schema\/person\/f023d988086a844cf27e25d0dd97e239"},"headline":"A IA Que Prev\u00ea Complica\u00e7\u00e3o Card\u00edaca Infantil \u2014 e a Armadilha Que Ningu\u00e9m Mostra","datePublished":"2026-07-22T23:16:37+00:00","dateModified":"2026-07-22T23:16:50+00:00","mainEntityOfPage":{"@id":"https:\/\/inovamed.pro\/?p=2792"},"wordCount":5771,"commentCount":0,"publisher":{"@id":"https:\/\/inovamed.pro\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/inovamed.pro\/?p=2792#respond"]}]},{"@type":"WebPage","@id":"https:\/\/inovamed.pro\/?p=2792","url":"https:\/\/inovamed.pro\/?p=2792","name":"A IA Que Prev\u00ea Complica\u00e7\u00e3o Card\u00edaca Infantil \u2014 e a Armadilha Que Ningu\u00e9m Mostra - INOVAMED","isPartOf":{"@id":"https:\/\/inovamed.pro\/#website"},"datePublished":"2026-07-22T23:16:37+00:00","dateModified":"2026-07-22T23:16:50+00:00","breadcrumb":{"@id":"https:\/\/inovamed.pro\/?p=2792#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/inovamed.pro\/?p=2792"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/inovamed.pro\/?p=2792#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/inovamed.pro\/"},{"@type":"ListItem","position":2,"name":"A IA Que Prev\u00ea Complica\u00e7\u00e3o Card\u00edaca Infantil \u2014 e a Armadilha Que Ningu\u00e9m Mostra"}]},{"@type":"WebSite","@id":"https:\/\/inovamed.pro\/#website","url":"https:\/\/inovamed.pro\/","name":"INOVAMED","description":"","publisher":{"@id":"https:\/\/inovamed.pro\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/inovamed.pro\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/inovamed.pro\/#organization","name":"INOVAMED","url":"https:\/\/inovamed.pro\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/inovamed.pro\/#\/schema\/logo\/image\/","url":"https:\/\/inovamed.pro\/wp-content\/uploads\/2024\/12\/cropped-DALL\u00b7E-2024-12-10-13.53.06-A-hyperrealistic-3D-rendering-of-a-half-human-brain-merged-with-circuit-board-patterns-viewed-from-a-slight-side-angle.-The-brains-left-hemisphere-s.webp","contentUrl":"https:\/\/inovamed.pro\/wp-content\/uploads\/2024\/12\/cropped-DALL\u00b7E-2024-12-10-13.53.06-A-hyperrealistic-3D-rendering-of-a-half-human-brain-merged-with-circuit-board-patterns-viewed-from-a-slight-side-angle.-The-brains-left-hemisphere-s.webp","width":1706,"height":1023,"caption":"INOVAMED"},"image":{"@id":"https:\/\/inovamed.pro\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/inovamed.pro\/#\/schema\/person\/f023d988086a844cf27e25d0dd97e239","name":"mbulabarros","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/inovamed.pro\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b45ea8fc03f19632f2c0e1180c867958fb387b48b3fe9af6e41ad80bbcf0d3c9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b45ea8fc03f19632f2c0e1180c867958fb387b48b3fe9af6e41ad80bbcf0d3c9?s=96&d=mm&r=g","caption":"mbulabarros"},"sameAs":["https:\/\/inovamed.pro"],"url":"https:\/\/inovamed.pro\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/inovamed.pro\/index.php?rest_route=\/wp\/v2\/posts\/2792","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inovamed.pro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/inovamed.pro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/inovamed.pro\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/inovamed.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2792"}],"version-history":[{"count":1,"href":"https:\/\/inovamed.pro\/index.php?rest_route=\/wp\/v2\/posts\/2792\/revisions"}],"predecessor-version":[{"id":2793,"href":"https:\/\/inovamed.pro\/index.php?rest_route=\/wp\/v2\/posts\/2792\/revisions\/2793"}],"wp:attachment":[{"href":"https:\/\/inovamed.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2792"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/inovamed.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2792"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/inovamed.pro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2792"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}